Prasad et al.’s analysis of plasma and prostate tissue samples identified 54 molecules with significantly altered expression in mice with prostate cancer revealing that NSAIDs’protective effects linked to reduced CD93 expression [171]. This evidence concerns the gene CD93 and prostate carcinoma.